Shoulder-to-shoulder with your team.

Greg Plunkett is our CEO and Managing Director of Accelagen, founding the company in 2010. He is an innovative, values-driven and forward-thinking senior regulatory affairs professional. Greg has close to 30 years of experience in product development, quality and management. Driving excellence, innovation and ingenuity, he is a passionate advocate for healthcare accessibility and bringing the best technologies and innovation to the masses.

Rosa Maria Plunkett is Accelagen’s Executive Director of Project Implementation, bringing over 20 years’ experience in clinical research and hospital settings with clients ranging from small biotechs to large multinational pharmaceutical companies. With her signature warmth and patience, Rosa fosters an inclusive, flexible and solution-driven environment. She's also passionate about developing her growing team and giving them mentorship and guidance to accelerate the future of human health and wellness. Importantly, Rosa’s skill and experience maximises study outcomes and efficiencies for our partners.

Kylie Lord is a skilled leader in financial management with over 20 years’ global experience in the financial services sector. Her experience and insights are a valuable asset to support Accelagen solidify its financial foundations and enable sustainable, long-term growth. Although an accountant on paper, Kylie is ultimately a people person and her enthusiasm, passion, and focus on making a positive contribution to the world.

Dr. Eleanor (Elle) Guest is part of Accelagen’s executive leadership team overseeing the operational functions. With over a decade of experience in clinical operations management and leadership in business expansion across Asia Pacific, Elle has the knowledge and track record to work collaboratively and effectively with diverse multi-disciplinary teams.

Elle also brings over five years’ experience driving data-driven strategy planning, leading feasibility and patient recruitment teams, and previous roles incorporating regulatory affairs, resource forecasting and workforce management. Her focus on process critique and improvement, and proactive and adaptable leadership results in an engaged workforce and efficient delivery of high-quality results for partners and patients alike.

As a specialist in Quality Assurance, Maxine brings to Accelagen’s leadership team a wealth of clinical trials and quality management experience gained from more than 20 years in the pharmaceutical industry. Her extensive career spans roles including study coordinator through to clinical operations positions and into quality management and expert Good x Practice (GXP) auditor. Her experience has contributed to her in-depth knowledge of quality requirements and understanding of Good Clinical Practice (GCP) compliance and the drug development process. Maxine is a passionate advocate for the role of quality management systems in achieving high quality clinical trials service delivery and ultimately improved healthcare outcomes for patients.

As Head of Data Management, Janus Rowlan D. Relos leads the development of our strong data infrastructure capability and provides strategic oversight for clinical trial databases. With over 20 years’ progressive experience in clinical research and data management, Janus is a specialist in compliant Good Clinical Practice (GCP), CDISC standards, and regulatory requirements for global clinical trials.

Janus has a proven track record in leading cross-functional teams, optimising data workflows, and fostering staff development, bolstered by an academic career and formerroles with sponsors and clinical research organisations (CROs). Janus specialises in database design for electronic data capture (EDC) systems and is skilled in statistical analysis.He blends technical expertise with a dedication to advancing clinical research through innovation and adherence to compliance standards.

As Accelagen’s Head of Biostatistics, Rebecca leads our team of highly skilled and experienced biostatisticians and statistical programmers. With over 10 years’ experience inclinical research, she is passionate about the role of statistics in advancing medical science. With a strong academic foundation, she combines technical expertise with strategicoversight to support design, analysis and interpretation of complex clinical studies.

Rebecca is dedicated to ensuring that all analyses are conducted to the highest standards of scientific rigor and ethical responsibility. Her leadership helps drive data-informed decision making across the organisation supporting robust, high-quality research that ultimately benefits the future of human health.

‍

With 10 years of experience in the pharmaceutical industry and regulatory affairs across AU, NZ and LATAM, Daniela leads global product approvals with expertise and precision. Her experience spans the registration of biological medicines, new chemical entities, generic medicines, medical devices, and orphan drugs. Daniela has worked with a variety of clients, from small biotech to large multinational pharmaceutical companies, adapting to their unique needs. She holds a BSc (Hons) in Pharmaceutical Chemistry and Pharmacy, and a Master’s in Cancer Sciences from The University of Melbourne. Passionate about technology, continuous learning, mentoring others, working in multicultural environments, and bringing new medicines and technologies to patients, Daniela is committed to advancing regulatory excellence and patient outcomes.

Ano Chinogurei is a standout people and culture professional with over five years’ experience as a human resources (HR) generalist across various industries. Known for her calmand positive influence, Ano is passionate about cultivating vibrant organisational cultures, driving employee engagement, and enhancing operational efficiency. With a strategicHR approach, she is dedicated to creating inclusive, people-centric workplaces that empower individuals and drive long-term organisational success.